Diabetes researchers and bioinformaticians from the Icahn School of Medicine at Mount Sinai have developed a new understanding of how human beta cell regenerative drugs work. These drugs, developed at ...

Prof. Heiko Lickert is the director of the Institute of Diabetes and Regeneration Research at Helmholtz Munich, professor at the Technical University of Munich (TUM), and member of the German Center ...

A team of researchers has made a breakthrough in diabetes treatment, uncovering a way to regenerate human insulin-producing beta cells. Their discovery, published in Science Translational Medicine, ...

A new study, which appears in Science Translational Medicine, investigates an experimental drug combination for the treatment of type 1 and type 2 diabetes. According to the paper, the treatment ...

Researchers and clinicians at Joslin Diabetes Center have established a Center for Cell-Based Therapy for Diabetes (CCTD), the goal of which is to lead the development and translation of cell-based ...

Millions of people with type 1 or 2 diabetes worldwide rely on insulin injections or medications to keep their blood sugar in check. The disease results from the destruction of the pancreas’s finite ...

The beta cells even began to slowly reproduce. “mAb43 in combination with insulin therapy may have the potential to gradually reduce insulin use while beta cells regenerate, ultimately eliminating the ...

Researchers have developed a method to direct stem cells to form specific structures. By triggering the expression of specific genes in mouse embryonic stem cells, synthetic organizer cells were ...

Share on Pinterest Research in mice is assessing the potential of an experimental drug that may help reverse diabetes. Image credit: Tatiana Timofeeva/Stocksy. A recent study in mice finds that a ...